Microdermabrasion to reduce fine lines and wrinkles as well as mild acne scarring and discolorations of the skin
Victoza is now FDA-approved to reduce the risk of heart attack, stroke, and heart-related death
Developed by Teva Pharmaceuticals, Uzedy is a once-monthly extended-release injectable suspension for adults with BD-I, used either as monotherapy or adjunctive therapy to lithium or valproate
Safety Considerations and Who Should Evaluate Compounded Semaglutide Compounded semaglutide is not appropriate for patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe pancreatitis, or severe gastrointestinal disease
Our physicians monitor you continuously to ensure your safety, screen for any health changes, and adjust your care as needed throughout your treatment journey